[ET Net News Agency, 15 July 2026] INNOGEN-B (02591) rose 10.7% to HK$8.98.
It hits an intra-day high of HK$9, and an intra-day low of HK$8.22. The total shares traded was 2.01 million, with a value of HK$17.26m. The active buy/sell ratio is 59:41, with net buying turnover of HK$3.21m. CHINA INNOVATION MARKET SER accounts for greatest net responsive buying turnover of HK$361,771, with volume weighted average price of HK$8.556. CHINA INV INFO accounts for greatest net responsive selling turnover of HK$1.22m, with volume weighted average price of HK$8.621.
Basic Information| Nominal | 8.980 | % Chg | +10.73% |
| High | 9.000 | Low | 8.220 |
| Shares Tr | 2.01m | Turnover | 17.26m |
| 10-D SMA | 8.118 | %H.V | 88.869 |
| 20-D SMA | 7.847 | VWAP | 8.591 |
| 50-D SMA | 10.184 | RSI14 | 52.166 |
Status: Active buy/sell ratio is 59:41, with net buying turnover of HK$3.21m
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| INNOGEN-B (02591) | 8.98 | +10.73 |
| INNOVENT BIO (01801) | 97.35 | +8.11 |
| WUXI XDC (02268) | 63.65 | +8.80 |
| WUXI BIO (02269) | 39.64 | +3.77 |
| PEGBIO CO-B (02565) | 7.19 | +16.91 |
| JOINN (06127) | 24.34 | +9.64 |
| BEONE MEDICINES (06160) | 190.60 | +2.58 |
| SKB BIO (06990) | 553.00 | +11.00 |
| AKESO (09926) | 103.30 | +7.77 |
| REMEGEN (09995) | 86.80 | +5.21 |
(ed)
Nominal 
